Author: Michelle Dryden

Michelle Dryden has come full-circle back to the exciting world of Journalism, news, and media. Dryden is an Independent Multimedia Journalist. She graduated with honors from Full Sail University. Dryden received the Advanced Achievement Award from Full Sail University's New Media Journalism Master's degree program, in June 2013. With journalism experiences in both digital and traditional journalism since 1996, she is a news veteran. The Media Pub News blog publishes core news and community features. What's your story? Email me at mdryden@themediapub.com. Cheers!!!
Business, Health Care

DESTINY-Breast05 head-to-head phase 3 trial of ENHERTU® versus T-DM1 initiated in patients with HER2 positive early breast cancer at high risk after neo-adjuvant therapy

TOKYO & MUNICH & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today announced the initiation of DESTINY-Breast05, a global phase 3, head-to-head trial of ENHERTU® (fam-trastuzumab deruxtecan-nxki) versus ado-trastuzumab emtansine (T-DM1) as adjuvant therapy in patients with

Business

Elmer Bancorp, Inc. announces third quarter 2020 financial results

ELMER, N.J.–(BUSINESS WIRE)–ELMER BANCORP, INC. (“Elmer Bancorp” or the “Company”) (OTC Pink: ELMA), the parent company of The First National Bank of Elmer (the “Bank”), announces its operating results for the three and nine months ended September 30, 2020. For the three